key: cord-0823185-za3caz14 authors: Goswami, Rudra Prosad; Ganguli, Bhaswati; Chatterjee, Moumita title: Endemic infections, vaccinations, and variability of SARS‐COV2 worldwide epidemiology: A cross‐sectional study date: 2021-03-01 journal: J Med Virol DOI: 10.1002/jmv.26875 sha: f42920ec7ac790af6d77c9af42c0ebd4201ab96c doc_id: 823185 cord_uid: za3caz14 The present article aims to analyze epidemiologic aspects of the novel coronavirus pandemic (COVID‐19) over different countries across the globe. While analyzing the overall spread of the disease, clusters of countries could be identified where the population‐adjusted number of cases and mortality rates (MRs) were significantly different from the others. To draw a comparison over the countries at the same stage of infection, the nature and spread of the infection was evaluated at the 90th day of the pandemic for each country. It was observed that the countries with prevalent malarial transmission tended to have lesser population‐adjusted COVID‐19 caseloads. It was further observed that high population coverage of the Bacillus Calmette–Guérin vaccination was negatively associated with population‐adjusted caseloads and MRs due to COVID‐19. The present cross‐sectional study is an attempt to bring in several social, economic, and structural confounders into understanding of the nature and spread of this novel pandemic globally. The novel coronaviral disease-2019 (COVID-19) is a new human respiratory tract infection that has grown into a pandemic. 1 Despite having a worldwide distribution, there exists significant country-to-country and continent-to-continent variation of disease spread, extent, and severity. Interestingly the mortality rates (MRs) or case fatality rates are different in different countries at the same stage of contagion, for example, both Spain and Italy experienced higher death statistics compared to China at the same stage of infection. 2 At the time of writing SARS-CoV-2 has killed more than 571,000 people, with over 12 million infected, and has engendered a global economic shutdown, perhaps more serious than the great depression of the 1930s. 3 While it is predicted that the virus may remain entrenched in various pockets of populations and may give rise to a multitude of coming epidemics and global health crises, only an effective and safe vaccine can curb the spread of the virus. It has been suggested that till an effective, safe and specific COVID-19 vaccine arrives, the Bacille Calmette-Guérin (BCG) vaccine may serve as an interim candidate. 3 On the other hand it has also been suggested that COVID-19 mortality is markedly higher in countries without a widely practiced BCG vaccination policy. 4 These observations could be of biological value or could be just "curious statistical banalities." To address this issue, we designed and conducted a cross-sectional study to test any association of country-wise COVID-19 epidemiology with different vaccination policies, endemic infectious diseases, and social confounders like developmental indices and airline travel. In this study, we started with 184 countries across the world and collected data on the following variables (wherever available) for each of them related to COVID-19: Number of COVID-19 infected individuals, deaths, recoveries, and the total number of tests performed in the first 90 days starting from the day of detection of the first case (for the countries which have not reached 90 days of infection till June 04, 2020; data were taken till June 04, 2020). In addition to the above information, we collected data on the following additional variables from the latest available population estimate: We collected data from freely accessible online data repositories on the following aspects: COVID-19 related data (number of cases, number of deaths, number of tests) at the 90th day of onset of first reported case in a particular country or on 4th June 2020 (whichever is earlier) 5 ; malaria, TB, and HIV prevalence (number of cases) 6-8 ; percentage population covered by the following vaccines: BCG, DTP1, haemophilus influenzae b vaccine (HiB), measles vaccine, poliovaccine (IPV1), RCV 9 ; population per country and HDI of the countries [10] [11] [12] ; and number of airline passengers 13 ; and number of COVID-19 tests done. 14 2.2 | Categorization of countries, for the purpose of comparison of COVID-19 statistics, was done in the following manner: Countries were categorized into various classes for comparison of COVID-19 related epidemiology based on the following classification scheme: i. Vaccination: countries were categorized in a bipartite manner based on <95% or ≥95% coverage of each vaccine studied; ii. Malaria transmission: malaria-free countries (no reported indigenous malaria cases), mild-moderate malaria transmission (≤100,000 cases per 1 million population) and high malaria transmission (>100,000 cases per 1 million population); iii. TB prevalence: mild (<5 cases per 100,000 population), moderate (5-99 cases per 100,000 population) and high (≥100 cases per 100,000 population); iv. HIV prevalence: Low prevalence (<1000 per million population), moderate prevalence (≤10,000, ≥1000 per million population), and high prevalence (>10,000 per million population). Comparison of COVID-19 cases, MR and RR were compared among various country-wise categories as described above were done and odd's ratios with confidence intervals were obtained. Next to allow for confounders a multidimensional clustering technique (K-Means Clustering 4 ) was used to classify the countries into a number of clusters or groups and thereby identifying the countries which are similar in nature. Instead of classifying the countries based on only a single variable, for example, coverage of any particular vaccine, it would be useful to analyze the characteristics of the groups, constructed using the coverage of more than one vaccine. The method helps us to analyze and access the impact of the interaction of several vaccines which is otherwise difficult to measure. All statistical analysis were done using the software R (version 3.6.1.). We begin with comparing COVID-19 cases to previously reported malaria prevalence. There is a negative correlation between number of malaria cases per million and COVID-19 cases per million Relationship of number of COVID-19 cases (population adjusted) with vaccine coverage statistic is detailed in Table 1 . Countries with lower coverage of BCG, measles, and Rubella-containing vaccine (RCV vaccine) coverage had significantly higher proportion of cases. Regarding the outcome of COVID-19, the only significant relation was with BCG vaccination coverage which was negatively correlated with MR and positively with recovery rate (RR). The map in Figure 1A is showing the MR due to COVID-19 for the different countries. The MR is higher for countries like France, Spain, UK, and Italy. Figure 1B is showing the RR from COVID-19 across different countries. Figure 1C shows the coverage of BCG vaccination for the countries across the globe, which indicates that countries like the United States, Canada, France, Italy, Spain, and the UK are the ones having the least coverage of BCG. The scatter plot in Figure 2A is showing that the lesser the BCG coverage, the more fatal the disease turns out to be. Figure 2B is showing the relationship between BCG coverage and RR per million infected during the COVID-19 pandemic. From Table 1 , it is obvious that RR hardly depends on the vaccine coverage (other than BCG). This phenomenon is quite similar to that of MR. Results from the clustering experiments are shown in of basophils and phagocytic macrophages and modulation the complement system, among others. 28 We observed in the present cross-sectional study, that malaria endemicity is associated with reduced COVID-19 cases and BCG vaccination is associated with reduced mortality. As shown in Figure 1C , for the countries like Italy, France, Spain, Sweden, a very lower BCG coverage has been observed on the other hand, Figure 1A suggests that the MRs are surprisingly high for those countries. This leads us to believe that the MRs of these countries are likely to be higher due to vaccine coverage. We refined the results by including multiple confounders like other commonly used vaccines, several other endemic infections, age structure of the population and societal confounders like airline passengers, HDI and number of tests performed to understand whether the correlations and associations that we have obtained are just spurious or it has a strong causality behind. However, the inherent limitations of these kinds of studies persist, like proxy-based measurement, lack of individual level data, potential for systematic differences between areas in recording disease frequencies and measurement of exposures. Also, along with the clustering technique, some other multivariate learning algorithms can be implemented here for better classification. The present study does not consider the current scenario (after the pandemic hits the countries) of the airline passengers and its impact on the infection counts. This is important as many countries closed their airspace which should also be relevant information for the present study. Also, the result of the present analysis is applicable for the dynamics of the first three months of the pandemic only. Nonetheless, we provide evidence that BCG and malaria exposure might be beneficial against this current pandemic. This study provides credence to the hypothesis that training of immunity by BCG vaccination and endemic parasitic exposure may be particularly beneficial against such viral pathogens and vaccine efforts should envisage using such trained immunity as an important tool against emerging pathogens. The authors declare that there are no conflict of interests. Rudra P. Goswami is responsible for conceptualizing the theme of the paper and the overall interpretation of the results. Bhaswati Ganguli is responsible for conceptualizing the statistical analysis and the interpretation of the results and Moumita Chatterjee is responsible for conceptualizing and executing the statistical analysis and the interpretation of the results. The peer review history for this article is available at https://publons. com/publon/10.1002/jmv.26875 The data that primarily support the findings of this study are openly available in worldometer at https://www.worldometers.info/coronavirus/, reference number (accessed on 4th June, 2020). Other details are included within the Reference section. Moumita Chatterjee http://orcid.org/0000-0003-3475-687X Clinical features of patients infected with 2019 novel coronavirus in Wuhan The battle against COVID-19: mortality in Italy BCG-induced trained immunity: can it offer protection against COVID-19? Is BCG vaccination causally related to reduced COVID-19 mortality? World Health Organisation. 2020. Global vaccine monitoring summary World Bank Open Data United Nations Development Programme United Nations Development Programme Number of COVID-19 tests are obtained from the following two websites and accessed on 4th Nonspecific and sex-differential effects of vaccinations on child survival in rural western India Defining trained immunity and its role in health and disease Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination Inhibition of Plasmodium falciparum growth in vitro by CD4+ and CD8+ T cells from non-exposed donors Natural' T cells responsive to malaria. evidence implicating immunological cross-reactivity in the maintenance of TCR alpha beta+ malaria-specific responses from non-exposed donors Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi Lyon (FR): International Agency for Research on Cancer (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Plasmodium co-infection protects against chikungunya virus-induced pathologies Co-infection with chikungunya virus alters trafficking of pathogenic CD8(+) T cells into the brain and prevents Plasmodium-induced neuropathology Infection against infection: parasite antagonism against parasites, viruses and bacteria Endemic infections, vaccinations, and variability of SARS-COV2 worldwide epidemiology: A cross-sectional study